BLOG

Studies Highlight Zofran Birth Defect Risk


Zofran Birth Defect Lawyer

Zofran (ZUPLENZ ®) is a drug used to treat nausea and vomiting in those undergoing cancer treatments, such as radiation and chemotherapy. It is also sometimes used to help those who suffer nausea from anesthesia following surgery. Zofran has also been prescribed to pregnant women suffering from morning sickness. GlaxoSmithKline marketed the drug as a remedy for morning sickness, even though it was not approved by the Food and Drug Administration for that specific purpose. As a result, many babies have been born with serious and debilitating birth defects.

Generic Name: ondansetron (oral) (on DAN se tron)
Brand Names: Zofran, Zofran ODT, Zuplenz

Zofran caused intrauterine death and fetal malformationsResearch conducted by the US Centers for Disease Control has shown that women who used Zofran during pregnancy were more than twice as likely to have a baby born with cleft palate. Another study, conducted by the University of Western Australia, showed that women exposed to ondansetron – the active ingredient in Zofran – increased the prevalence of birth defects by 20%. Babies were also six times more likely to develop malformed kidneys. A Danish study found that babies exposed to ondansetron while in the womb were nearly five times more likely to develop congenital heart defects.

What is Zuplenz?

Zuplenz (ondansetron) blocks the actions of chemicals in the body that can trigger nausea and vomiting.

Zuplenz is used to prevent nausea and vomiting that may be caused by surgery or by medicine to treat cancer (chemotherapy or radiation).

Zuplenz is not for preventing nausea or vomiting that is caused by factors other than cancer treatment or surgery.

Zofran– increased the prevalence of birth defectsGlaxoSmithKline started receiving reports of birth defects more than 20 years ago. In 2012, the company faced criminal charges for illegally promoting Zofran for unapproved uses, including treatment of morning sickness. The company paid $3 billion to settle claims. But, the company’s legal battles are far from over.

Another lawsuit was filed earlier this year. Since then, seven other women have come forward with claims that Zofran use caused their babies to be born with birth defects. The alleged birth defects include cleft palate, heart defects, fluid on the brain, heart murmur and developmental delays.

GlaxoSmithKline does not warn Zofran users about birth defects, despite the fact that the company has received more than 200 complaints. Numerous lawsuits allege the company pays doctors to prescribe it to pregnant women. In addition, the lawsuits allege that the company knew about these possible risks, but failed to inform physicians and patients. Prior to Zofran approval, the company performed testing on rodents and rabbits and found that ondansetron caused intrauterine death and fetal malformations.

Pharmaceutical companies have a duty to create safe drugs and to sufficiently warn consumers and patients of all known side effects and risks.  If you or someone you know used Zofran while pregnant and delivered a child with a birth defect, contact Nadrich & Cohen, LLP today for a free consultation.

Do I Have A Case?

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

 

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

 

Why
Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


March 20, 2019

Valsartan Dangers: 3 Things You Should Know

Several drugs containing Valsartan have been  recalled in the U.S. because they contain impurities which may be cancer risks. You may be eligible for financial compensation if you took a drug containing Valsartan and have been diagnosed with cancer.


March 15, 2019

Expert Testifies Before House Subcommittee Regarding Talc Use And Ovarian Cancer Link

A United States House of Representatives subcommittee, on March 12th, 2019, looked into whether they should give the Food and Drug Administration (FDA) the power to more strictly regulate cosmetics, including talcum powder and products containing talc.

 

We are Personal Injury Lawyers representing accident victims throughout California.
For 30 years, the law firm of Nadrich & Cohen, LLP has helped injury victims
obtain the compensation they deserve.